search
Back to results

Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects

Primary Purpose

Hyperlipidemias

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Walnut-enriched Group
Sponsored by
Eastern Mediterranean University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hyperlipidemias focused on measuring Serum lipids, Hyperlipidemia, Walnut

Eligibility Criteria

30 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Hyperlipidemic patients who are not using any lipid lowering medications
  • Non-smoker
  • No alcohol consumption
  • Individuals who are having ≤30kg/m2
  • Individuals who do not have any allergy for nut consumption
  • Female participants who are not pregnant or breastfeeding
  • Individuals should not be in a weight loss programme
  • Having not consumed regular nuts for the last 1 month,
  • Except hypertension, they should not have other chronic diseases (such as diabetes, chronic renal failure)
  • No intense exercise

Exclusion Criteria:

  • Failure to meet the criteria for inclusion criteria.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Experimental

    Arm Label

    Control Group

    Interventional Group

    Arm Description

    In 'Control group' participants had 6 week follow-up without any intervention.

    In 'Interventional group' participants had 6 week follow-up and during that period of time, they were asked to consume 40g/day walnut. Participants in intervention group was ensured to consume all 40g of walnut every day, during their snack times for 6 weeks.

    Outcomes

    Primary Outcome Measures

    Reduction in serum lipids and fasting glucose levels
    In both group, participants have decreased serum total cholesterol and LDL-cholesterol.However especially walnut-enrcihed group significantly changed fasting glucose and insulin levels.

    Secondary Outcome Measures

    Full Information

    First Posted
    September 19, 2018
    Last Updated
    September 21, 2018
    Sponsor
    Eastern Mediterranean University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03680027
    Brief Title
    Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects
    Official Title
    Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects: A Randomized-Controlled Trial: A Randomized-Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2018
    Overall Recruitment Status
    Completed
    Study Start Date
    July 10, 2015 (Actual)
    Primary Completion Date
    August 27, 2015 (Actual)
    Study Completion Date
    September 30, 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Eastern Mediterranean University

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Walnuts have been shown to reduce serum lipids in hyperlipidemic individuals with a well-controlled feeding trials. Current study have been determined the effects of daily walnut consumption on serum lipids, fasting glucose and insulin levels in hyperlipidemic individuals.
    Detailed Description
    In this, randomized controlled trial, mild to moderate hyperlipidemic subjects were randomly divided into 2 groups as walnut-enriched (n=20) and control (n=17) groups for 6 weeks. All subjects adhered to a medical nutrition therapy as low-fat and low-cholesterol diet. The walnut-enriched group was supplemented with 40 g/day of walnuts added to their diets. In order to follow nutritional status of subjects, they were visited every 15 days (in total 4 times). Anthropometric measurements of the subjects were taken and were monitored at each visit during the study. Blood samples were measured at the beginning and again at the end of the study.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hyperlipidemias
    Keywords
    Serum lipids, Hyperlipidemia, Walnut

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    37 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Control Group
    Arm Type
    No Intervention
    Arm Description
    In 'Control group' participants had 6 week follow-up without any intervention.
    Arm Title
    Interventional Group
    Arm Type
    Experimental
    Arm Description
    In 'Interventional group' participants had 6 week follow-up and during that period of time, they were asked to consume 40g/day walnut. Participants in intervention group was ensured to consume all 40g of walnut every day, during their snack times for 6 weeks.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Walnut-enriched Group
    Intervention Description
    All subjects supplemented with 40 g/day of walnuts for 6 weeks.
    Primary Outcome Measure Information:
    Title
    Reduction in serum lipids and fasting glucose levels
    Description
    In both group, participants have decreased serum total cholesterol and LDL-cholesterol.However especially walnut-enrcihed group significantly changed fasting glucose and insulin levels.
    Time Frame
    Six weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    30 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Hyperlipidemic patients who are not using any lipid lowering medications Non-smoker No alcohol consumption Individuals who are having ≤30kg/m2 Individuals who do not have any allergy for nut consumption Female participants who are not pregnant or breastfeeding Individuals should not be in a weight loss programme Having not consumed regular nuts for the last 1 month, Except hypertension, they should not have other chronic diseases (such as diabetes, chronic renal failure) No intense exercise Exclusion Criteria: Failure to meet the criteria for inclusion criteria.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Gözde Okburan
    Organizational Affiliation
    Eastern Mediterranean University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects

    We'll reach out to this number within 24 hrs